Clear Eyes Maximum Itchy Eye Relief Liquid
FDA Recall NDC 67172-999
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Clear Eyes Maximum Itchy Eye Relief (NDC 67172-999). A significant event, classified as Class II, was initiated on Jul 29, 2026 by Prestige Brands Holdings, Inc.. The reported reason for this action was: "Lack of assurance of sterility. The recall is due to potential contamination"
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
Reported Recall Events
July 2026 Class II Recall: Lack of assurance of sterility. The recall is due to potential contamination
Recall Number
Class II Ongoing
Lack of assurance of sterility. The recall is due to potential contamination
Jul 29, 2026
Aug 19, 2026
39,060 15mL-bottles
Recall Profile & Regulatory Data
Event ID
99532
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
Prestige Brands Holdings
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide in the USA.
Product Description
CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per dropper bottle, Sterile, Dist. by Medtech Products Inc., Tarrytown, NY 10591, a Prestige Consumer Healthcare Company. NDC: 67172-999-01 UPC 6 78112 65920 3
Batch or Lot Expiration Information
Lot# Lot 2552A, Exp 09/30/2027
Affected Packages Involved in this Recall
67172-999-01Product
67172-999-06Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
